Kamleshun Ramphul, Shaheen Sombans, Renuka Verma, Petras Lohana, Balkiranjit Kaur Dhillon, Stephanie Gonzalez Mejias, Sailaja Sanikommu, Yogeshwaree Ramphul, Prince Kwabla Pekyi-Boateng
BACKGROUND: At the start of the COVID-19 pandemic, several experts raised concerns about its impact on Multiple Sclerosis (MS) patients. This study aims to provide a perspective using the biggest inpatient database from the United States. METHOD: We screened for COVID-19 cases between April to December 2020, via the 2020 National Inpatient Sample (NIS). Various outcomes were analyzed. RESULTS: We identified 1,628,110 hospitalizations with COVID-19, including 7620 (...
July 2024: Neurohospitalist